A major US-based pharmacy chain has expanded a drug recall after regulators flagged potential contamination risks, following an earlier warning issued to the company over similar concerns. Authorities have not yet specified the nature of the contamination but have urged consumers to avoid the affected products. The recall comes amid heightened scrutiny of pharmaceutical safety standards, with the pharmacy now facing renewed public and regulatory attention. Health officials are advising patients to check their medications and contact their providers if they believe they may have been exposed.


The US-based pharmacy that issued the initial recall had previously received a warning.